- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01862484
Neuroimaging of Diet in ADHD: Phase I (FTF)
March 10, 2015 updated by: Steven Pliszka, The University of Texas Health Science Center at San Antonio
Neuroimaging of Diet and Medication in the Treatment of ADHD
Children with Attention Deficit Hyperactivity Disorder (ADHD) aged 9-12 years of age will be placed on a restriction diet for a 5 week period.
Children will be randomized to either receive daily snacks that conform to the diet or will violate the diet (Ruse diet) in a double blind fashion.
It is hypothesized that children who are consistently on the restricted diet (relative to those on the ruse diet) will show improvements in ADHD symptoms.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The ADHD rating scale (RS) will be the principal behavioral outcome measure.
We hypothesize that children on restriction diet will have significantly lower ADHD RS scores after 5 weeks relative to the Ruse diet group.
In addition children will undergo functional magnetic resonance imaging (fMRI) at baseline and again at 5 weeks.
Children will perform a flanker task known to engage the dorsolateral prefrontal cortex (DLPFC) and the anterior cingulate cortex (ACC) during attention tasks.
The children will also perform will look at pictures of appealing and unappealing food and rate whether they would like to eat it or not.
This task is known to activate the ventral striatum (VS) (reward processing).
A secondary hypothesis is whether children on the restricted diet will show changes in activity and connectivity of areas (DLPFC, ACC, VS) relative to those on the Ruse diet.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
San Antonio, Texas, United States, 78229
- University of Texas Health Science Center at San Antonio
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
9 years to 12 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 9-12 years
- Meets criteria for Attention Deficit Hyperactivity Disorder
- Parent must agree to use Study Diet Manual
Exclusion Criteria:
- Any Axis I psychiatric disorder other than Oppositional Defiant Disorder or Anxiety Disorder not requiring psychopharmacological management
- Not currently on any pharmacological agent other than medication for ADHD
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Restricted Diet
Child is on an additive, gluten free diet.
Child receives daily snacks which conform to the restrictive diet.
|
Child is on an additive, gluten free diet.
Child receives daily snacks which conform to the restrictive diet.
|
SHAM_COMPARATOR: Ruse Diet
Child is on an additive, gluten free diet.
Child receives daily snacks which violate the restrictive diet.
|
Child is on an additive, gluten free diet.
Child receives daily snacks which violate the restrictive diet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ADHD Rating Scale IV
Time Frame: 5 weeks
|
The ADHD Rating Scale is an 18 items scale containing items related to the diagnosis of Attention Deficit Hyperactivity Disorder (ADHD).
It is filled out by the parent.
Each item is rated 0-3, the range of scores is 0 to 54, with 25 being the score below which the patient is considered to be in remission.
Reference: DuPaul GJ, Power TJ, Anastopoulos AD, Reid R: ADHD Rating Scales-IV: Checklists, Norms and Clinical Interpretation.
New York, Guilford Press; 1998.
|
5 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Stevn R Pliszka, MD, The University of Texas Health Science Center at San Antonio
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2013
Primary Completion (ACTUAL)
December 1, 2014
Study Completion (ACTUAL)
December 1, 2014
Study Registration Dates
First Submitted
May 17, 2013
First Submitted That Met QC Criteria
May 21, 2013
First Posted (ESTIMATE)
May 24, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
March 13, 2015
Last Update Submitted That Met QC Criteria
March 10, 2015
Last Verified
March 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R21MH09680
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Disorder With Hyperactivity
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsRecruitingPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Karolinska InstitutetCompletedAttention Deficit Disorder With Hyperactivity (ADHD)Sweden
-
Rabin Medical CenterNG Solutions LtdRecruitingADHD - Attention Deficit Disorder With HyperactivityIsrael
-
Fondation LenvalCompletedAttention Deficit Disorder With Hyperactivity | Attention Deficit Disorder Without HyperactivityFrance
-
Clinical and Translational Genome Research Institute...Children's Specialized HospitalTerminatedAttention Deficit Disorders With HyperactivityUnited States
-
University of PennsylvaniaCompletedAttention Deficit Disorder With Hyperactivity (ADHD)United States
-
Nemours Children's ClinicCompletedAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit DisorderUnited States
-
Massachusetts General HospitalRecruitingAttention Deficit Disorder With Hyperactivity | Attention Deficit DisorderUnited States
-
New River PharmaceuticalsShireCompletedAttention Deficit Hyperactivity Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersUnited States
Clinical Trials on Restricted Diet
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Vascular Diseases | Hypertension
-
Heart and Diabetes Center North-Rhine WestfaliaCompleted
-
Azienda Ospedaliera OO.RR. S. Giovanni di Dio e...Federico II University; University of Modena and Reggio EmiliaUnknown
-
Norwegian University of Science and TechnologyMonash University; Portuguese Research CouncilCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Vascular Diseases | Hypertension
-
Cedars-Sinai Medical CenterCompletedProstate CancerUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)National Institute on Aging (NIA)CompletedHeart Diseases | Cardiovascular Diseases | Vascular Diseases | HypertensionUnited States
-
Huashan HospitalCompleted
-
National University Hospital, SingaporeEnrolling by invitationObesity | Metabolic Syndrome | Weight Loss | Ketogenic DietingSingapore
-
Maya GuglinTerminatedHeart FailureUnited States